71 – 80 of 2256
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
An uncommon MALady : is the AnWj puzzle complete?
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Monoclonal gammopathy of undetermined significance and the risk of thrombotic events : Results from iStopMM, a prospective population-based screening study
2024) In British Journal of Haematology(
- Contribution to journal › Article
-
Mark
Concizumab prophylaxis in people with haemophilia A or haemophilia B without inhibitors (explorer8) : a prospective, multicentre, open-label, randomised, phase 3a trial
(
- Contribution to journal › Article
-
Mark
MYC protein is a high-risk factor in mantle cell lymphoma and identifies cases beyond morphology, proliferation and TP53/p53 – a Nordic Lymphoma Group study
(
- Contribution to journal › Article
-
Mark
SMS121, a new inhibitor of CD36, impairs fatty acid uptake and viability of acute myeloid leukemia
(
- Contribution to journal › Article
-
Mark
TOPORS E3 ligase mediates resistance to hypomethylating agent cytotoxicity in acute myeloid leukemia cells
(
- Contribution to journal › Article
-
Mark
Autoimmune effector mechanisms associated with a defective immunosuppressive axis in immune thrombocytopenia (ITP)
(
- Contribution to journal › Scientific review
-
Mark
Gene Therapy with Fidanacogene Elaparvovec in Adults with Hemophilia B.
(
- Contribution to journal › Article
-
Mark
BAY 81-8973 Demonstrates Long-Term Safety and Efficacy in Children With Severe Haemophilia A : Results From the LEOPOLD Kids Extension Study
2024) In European Journal of Haematology(
- Contribution to journal › Article
-
Mark
Anticoagulation for splanchnic vein thrombosis in myeloproliferative neoplasms : a systematic review and meta-analysis
(
- Contribution to journal › Article